Experiments in mice may help boost newly FDA-approved therapy for spinal muscular atrophy
Johns Hopkins researchers along with academic and drug industry investigators say they have identified a new biological target for treating spinal muscular atrophy. They report they have evidence that an experimental medicine ...
Jan 9, 2017
0
32